These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 19640746

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Ketamine from an anticonvulsant perspective].
    Mion G, Rüttimann M.
    Ann Fr Anesth Reanim; 1997; 16(8):1045-6. PubMed ID: 9750654
    [No Abstract] [Full Text] [Related]

  • 27. Ketamine followed by memantine for the treatment of major depression.
    Kollmar R, Markovic K, Thürauf N, Schmitt H, Kornhuber J.
    Aust N Z J Psychiatry; 2008 Feb; 42(2):170. PubMed ID: 18197514
    [No Abstract] [Full Text] [Related]

  • 28. Ketamine for restless legs syndrome.
    Friedman R.
    Anesth Analg; 2003 Apr; 96(4):1238-1239. PubMed ID: 12651704
    [No Abstract] [Full Text] [Related]

  • 29. Reconsidering Neuroprotection in the Reperfusion Era.
    Savitz SI, Baron JC, Yenari MA, Sanossian N, Fisher M.
    Stroke; 2017 Dec; 48(12):3413-3419. PubMed ID: 29146878
    [No Abstract] [Full Text] [Related]

  • 30. Retinal ganglion cells, glaucoma and neuroprotection.
    Lipton SA.
    Prog Brain Res; 2001 Dec; 131():712-8. PubMed ID: 11420983
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Therapeutic coma or neuroprotection by anaesthetics.
    Mortier E, Struys M, Herregods L.
    Acta Neurol Belg; 2000 Dec; 100(4):225-8. PubMed ID: 11233677
    [Abstract] [Full Text] [Related]

  • 37. -(S)-Alpha-phenyl-2-pyridine-ethanamine Dihydrochloride-, a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia.
    Cregan EF, Peeling J, Corbett D, Buchan AM, Saunders J, Auer RN, Gao M, Mccarthy DJ, Eisman MS, Campbell TM, Murray RJ, Stagnitto ML, Palmer GC.
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1412-24. PubMed ID: 9400017
    [Abstract] [Full Text] [Related]

  • 38. NMDA receptor blockade prevents nitroglycerin-induced headaches.
    Roffey P, Mikhail M, Thangathurai D.
    Headache; 2001 Dec; 41(7):733. PubMed ID: 11554966
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.